Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (151-160 of 272) with videos related to

Pageof 28
Sort By:
European Urology Focus|February 11, 2018
Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Michael Froehner, Rainer Koch, Matthias Hübler, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2017
Quantification of MicroRNAs in Urine-Derived SpecimensSusanne Fuessel, Andrea Lohse-Fischer, Dana Vu Van, et al.
The Journal of Urology|November 16, 2004
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatmentKai Kraemer, Susanne Fuessel, Matthias Kotzsch, et al.
Urology|September 19, 2006
Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of ageMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urologic Oncology|April 19, 2011
Which comorbidity classification best fits elderly candidates for radical prostatectomy?Michael Froehner, Caroline Hentschel, Rainer Koch, et al.
BJU International|January 25, 2006
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancerDavid G McLeod, Peter Iversen, William A See, et al.
Nanotechnology|September 17, 2014
Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanismsKati Erdmann, Jessica Ringel, Silke Hampel, et al.
European Urology Focus|July 30, 2017
Validation of the Preoperative Score to Predict Postoperative Mortality in Patients Undergoing Radical CystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumorsWaldemar Kanczkowski, Piotr Tymoszuk, Monika Ehrhart-Bornstein, et al.
Urologia Internationalis|July 21, 2012
Competing mortality contributes to excess mortality in patients with poor-risk lymph node-positive prostate cancer treated with radical prostatectomyMichael Froehner, Albrecht Scholz, Rainer Koch, et al.
Pageof 28

Showing results (151-160 of 272) with videos related to

Sort By:
Pageof 28
European Urology Focus|February 11, 2018
Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Michael Froehner, Rainer Koch, Matthias Hübler, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2017
Quantification of MicroRNAs in Urine-Derived SpecimensSusanne Fuessel, Andrea Lohse-Fischer, Dana Vu Van, et al.
The Journal of Urology|November 16, 2004
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatmentKai Kraemer, Susanne Fuessel, Matthias Kotzsch, et al.
Urology|September 19, 2006
Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of ageMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urologic Oncology|April 19, 2011
Which comorbidity classification best fits elderly candidates for radical prostatectomy?Michael Froehner, Caroline Hentschel, Rainer Koch, et al.
BJU International|January 25, 2006
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancerDavid G McLeod, Peter Iversen, William A See, et al.
Nanotechnology|September 17, 2014
Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanismsKati Erdmann, Jessica Ringel, Silke Hampel, et al.
European Urology Focus|July 30, 2017
Validation of the Preoperative Score to Predict Postoperative Mortality in Patients Undergoing Radical CystectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumorsWaldemar Kanczkowski, Piotr Tymoszuk, Monika Ehrhart-Bornstein, et al.
Urologia Internationalis|July 21, 2012
Competing mortality contributes to excess mortality in patients with poor-risk lymph node-positive prostate cancer treated with radical prostatectomyMichael Froehner, Albrecht Scholz, Rainer Koch, et al.
Pageof 28